NATALIE BRADLEY: Open Payments
NPI 1346754751 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 71 payments from 19 companies in 2025. Trend: 2023 $1,901 · 2024 $974 · 2025 $1,400
Food & beverage: $1,401
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $180 |
| E.R. Squibb & Sons, L.L.C. | 14 | $175 |
| Merck Sharp & Dohme LLC | 8 | $167 |
| BridgeBio Pharma, Inc. | 2 | $151 |
| Novartis Pharmaceuticals Corporation | 6 | $142 |
| Actelion Pharmaceuticals US, Inc. | 5 | $105 |
| PFIZER INC. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Kestra Medical Technology Services, Inc. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: REPATHA, ELIQUIS, Attruby, LEQVIO, WINREVAIR, CAMZYOS, WAINUA, OPSUMIT.
Industry payments across GA — which companies pay providers there.
